• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Proteomics - Global Strategic Business Report Product Image

Proteomics - Global Strategic Business Report

  • ID: 347938
  • May 2014
  • Region: Global
  • 234 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for Proteomics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 82 companies including many key and niche players such as:

- ActivX Biosciences, Inc.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Bruker Daltonics, Inc.
- Caprion Proteomics, Inc.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW

Proteomics
The Current Spotlight
Proteomics: A Critical Drug Discovery Tool
Research to Dominate the Market in the Immediate Future
Proteomics Technologies: Growing in Significance
New Developments in Proteomics Technologies
Market Drivers/Trends/Challenges
Personalized Medicine Slowly Gaining Ground
Table 1: Drug Ineffectiveness for Select Therapeutic Categories as a Percentage of Patient Population (includes corresponding Graph/Chart)
Table 2: Global Population Statistics for the 65+ Age Group (2012) (includes corresponding Graph/Chart)
Table 3: Percentage of Population Aged 65 and Above in Europe, US, and Japan (1960-2030) (includes corresponding Graph/Chart)
Table 4: Elderly Population (65+ Years) as a Percentage of the Total Population: 2025 (includes corresponding Graph/Chart)
Advancements in Proteomics Bring Biomarkers into Limelight
List of US-FDA Approved Biomarkers for Cancer
Oncology
A Key Focus Area for Proteomics
Table 5: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart)
Table 6: New Cancer Cases in the World by Affected Site (2012) (in Thousands) (includes corresponding Graph/Chart)
Table 7: Cancer Incidence in Developed Nations by Site: 2012 (includes corresponding Graph/Chart)
Table 8: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal, and Liver Cancers (includes corresponding Graph/Chart)
Table 9: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus, and Liver Cancers (includes corresponding Graph/Chart)
Table 10: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer- Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart)
International Initiatives in the Proteomics Market
China All Set To Play a Major Role in the Proteomics Industry
Global Proteomics Sample Preparation Market
On a Growth Curve
Challenges Facing Proteomics Sample Preparation Market
Industrialization of Proteomics Research Propels Sample Preparation Technologies
Factors Limiting Market Growth
Impact of the Economic Recession on the Life Sciences Industry in Retrospect
Challenges Facing Proteomics Industry
Protein Chemistry and its Complexities
Quantitation
Integration of Data & Equipment
Data Validation
A Burning Issue
Standardization & Consistency
A Prime Concern
Incomplete and Disorganized Data

2. INDUSTRY COMPETITION

A Highly Fragmented Market
Tool Providers: Leading the Proteomics Market
Role of Contract Research Organizations
All Set to Increase in Proteomics

3. PRODUCT AND TECHNOLOGY OVERVIEW

Proteins, Proteome and Proteomics!!!
What are they?
Proteomics
An Introduction
Genesis of Proteomics
Components of Proteomics
Expression Proteomics
Functional Proteomics
Cell-map Proteomics
Structural Proteomics
Technologies and Proteomics
Proteomics and Genomics
Proteomics and Genomics: A Comparison
Protein Production Pathway: From Gene Expression to Functional Protein with Controls
From Genomics to Proteomics
Functional Genomics and Proteomics
Push from Genomic Information
An Insight into Proteomics Data Type and their Characteristics / Features
Standard Proteomics Approach
Sample Preparation
Step I
Protein Separation
Step II
Protein Visualization
Protein Expression Analysis-Step III
Image Analysis
Identify differentially expressed spots
Protein Identification
Step IV
Data Storage and Processing
Step V

4. OVERVIEW OF PROTEOMICS TECHNOLOGIES

A Snapshot of Various Proteomics Tools
An Insight into Various Proteomics Technologies and their Application Areas
Protein Separation
2-Dimensional Gel Electrophoresis (2DGE)
Elements of 2-DE Proteomics
Two -Dimensional Differential Gel Electrophoresis
Combining 2D Gel Electrophoresis with Mass Spectrometry (MS)
2D Capillary LC
Analytical Strength of LC-MS and MS/MS in Shotgun Protein Sequencing
Protein Characterization
Analysis of Protein through Mass Spectrometry
MS and Proteins
Comparison of MS Techniques
Applications of MS
Problems Associated with MS
Types of Analyzers or Filters
MALDI-TOF MS
MS/MS
SELDI-TOF
Laser Capture Microdissection
Tandem MS
Y2H, Yeast 2-Hybrid System
Sensitivity of Two-Hybrid Assays
Limitations of Y2H
Protein Microarrays
Market Influencers in Protein Microarrays Market
Chip Technology
Microfluidic Applications
Role of Bioinformatics in Proteomics
Bioinformatics Applications and Tools in Proteomics
MS Programs
2- DE gel Comparison
2-DE Databases
Databases of 2D-electrophoretic maps
Emerging Proteomics Technologies
MudPIT
ICAT
ICAT strategy: A solution to quantitative proteome analysis
Phage Display Technique
Advanced Proteomics Technologies: Structural Analysis Tools
X-ray Crystallography
Nuclear Magnetic Resonance (NMR)
In silico Modelling
Physicochemical Factors Constraining Metabolic Functions

5. END-USE APPLICATION AREAS

Proteomics in Drug Discovery and Diagnostics
Proteomics and Drug Discovery
Protein Microarrays: A New Tool for the Development of Pharmaceuticals
Proteomic Approaches Gain Prominence in Cancer Drug Discovery
Proteomics Technologies Used in Cancer Drug Discovery and Development

6. NEW PRODUCT LAUNCHES/DEVELOPMENTS

Proteome Sciences Validates Novel Protein Biomarkers
KineMed to Apply Its MS Proteomics Platform to Study Neurodegeneration
Agilent and MRM Proteomics Introduce PeptiQuant Kits for High -Quality Plasma Proteomic Analysis
Elsevier Launches ‘Translational Proteomics’ Open-Access Journal
Applied Biomics Introduces Global Protein Post- Translational Modification Profiling Service
AB SCIEX Launches New Column Chips
Applied Biomics Introduces New Mass Spectrometry Service
Norton Scientific Introduces Novel Specialist Applications Development Laboratory Service
Gentel Biosciences Introduces APiX™ Disease Profiling Kit
Integromics Introduces OmicsHub Proteomics 2.0
Bruker Introduces amaZon Speed Ion Trap Mass Spectrometers
Applied Biomics Introduces iTRAQ Service for Proteomics Research
Norton Scientifc Introduces New Lab Support Service for Rapid RNA/DNA and Protein Measurement
Bruker Launches MALDI Biotarget™
Thermo Fisher Launches UHLPC System
Kinexus Introduces Human Gene Online TranscriptoNET KnowledgeBase
Bruker Launches PRIME Integrated Proteomics Solution
Applied Biosystems Launches LS*LIMS Laboratory Automation Technology for Proteomics and Genomics
Kinexus Bioinformatics Introduces Online KiNET-AM Proteomics DataBase
Bruker Rolls Out CaptiveSpray Electrospray Ion Source for Proteomics Applications
Thermo Fisher Launches New Capabilities for Performing Proteomics Workflows
National Cancer Institute Introduces Clinical Proteomic Tumor Analysis Consortium for Cancer Studies
KinaSorb™
New Kit for Kinase Enrichment

7. RECENT INDUSTRY ACTIVITY

Retroscreen Virology Group Acquires Activiomics
Thermo Fisher Scientific Acquires Life Technologies Corporation
Fluidigm Corporation Buys DVS Sciences
Geneva Bioinformatics Collaborates with University of Washington
Applied Proteomics Partners with German Research Institute
Agilent Technologies Enters Agreement with SomaLogic
Biognosys Partners with CellnTEC
Proteome Sciences Enters Contract with Thermo Fisher Scientific
Agilent Technologies Partners with Sera Prognostics
Chicago Growth Partners Buys Caprion Proteomics from Thallion
GlaxoSmithKline Fully Acquires Cellzome
Proteome Sciences Signs Agreement with CHDI Foundation
Waters Corp. Inks Agreement with Nonlinear Dynamics
BioFocus Enters into Alliance with Activiomics
Great Point Partners Divests Caprion Proteomics
Glaxo Smith Kline Takes over Cellzome
Emerald BioSystems Changes Name to Emerald Bio
Bruker Unveils Novel Nano-Advance UHPLC System
Evotec Takes Over Kinaxo Biotechnologies
Kinaxo Biotechnologies and AstraZeneca Sign Agreement
Gentel Biosciences Takes over Eppendorf’s SilverQuant Trademark
Thermo Fisher Takes Over Fermentas International
KINAXO to Collaborate with Takeda
Dualsystems and Bulldog Bio Signs Exclusive Marketing Agreement
Novartis Enters into Agreement with SomaLogic
Sage-N Inks Exclusive Pact with the U.S. Army
Proteome Sciences Inks Agreement with Moffitt Cancer Center
Gentel Biosciences Enters into Agreement with Oregon Health & Science University
Evotec OAI Forms Joint Venture with MeITec to Collaborate on Drug Discovery Services

8. FOCUS ON SELECT KEY PLAYERS

ActivX Biosciences, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Bruker Daltonics, Inc.
Caprion Proteomics, Inc.
Digilab Genomic Solutions, Inc.
GE Healthcare
Geneva Bioinformatics S.A.
Hybrigenics SA
EMD Millipore/Merck Millipore Corp.
PerkinElmer, Inc.
Shimadzu Corporation
Sigma-Aldrich Corporation
Thermo Fisher Scientific
Waters Corp.
Xencor Inc.

9. GLOBAL MARKET PERSPECTIVE

Table 11: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 12: World Historic Review for Proteomics by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 13: World 15-Year Perspective for Proteomics by Geographic Region
Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A.Market Analysis
Current & Future Analysis
Personalized Medicine
A Major Driver for the Proteomics Market
Table 14: US Market for Hospital Cancer Therapies by Treatment Type (2004 and 2010): Percentage Breakdown of Revenues for Surgery, Chemotherapy Drugs, Radiation Therapy, Biotechnology-Based Drugs, and Others (includes corresponding Graph/Chart)
Cancer Presumes Epidemic Proportion in the US
Table 15: New Cancer Cases by Gender and Affected Site in the US (2013)
Proteomics to Provide POCT for Patients in Hospice Care
Leading Market for Rapid and Automated Microbiological Tests
Demographic Changes Offer Growth Opportunities
Table 16: North American Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
Proteomics Sample Preparation Market
FDA’s Antidote
New Product Launches
Strategic Corporate Developments
Key Players
B.Market Analytics
Table 17: The US Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 18: The US Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)

2. CANADA

A.Market Analysis
Rising Incidence of Chronic Diseases Spurs Proteomics Demand
Table 19: New Cancer Cases in Canada by Gender and Affected Site (2012) (includes corresponding Graph/Chart)
Table 20: New Cancer Cases in Canada by Province (2012) (includes corresponding Graph/Chart)
Table 21: New Cancer Cases in Canada by Age Group and Gender (2012) (includes corresponding Graph/Chart)
New Product Developments
Strategic Corporate Development
Caprion proteomics, Inc.
A Key Player
B.Market Analytics
Table 22: Canadian Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 23: Canadian Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)

3. JAPAN

A.Market Analysis
Demographics Drive Market Growth
Table 24: Percentage Breakdown of Japanese Population by Age Group (2012) (includes corresponding Graph/Chart)
Table 25: Over 65 Years Population in Japan (1950-2010) (includes corresponding Graph/Chart)
Shimadzu Corp.
A Key Player
B.Market Analytics
Table 26: Japanese Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 27: Japanese Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)

4. EUROPE

A.Market Analysis
Debt Crisis in Europe Affects Healthcare Industry
European Healthcare System: In a State of Transition?
Cancer Trends
Table 28: Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Aging Population to Drive Demand for Proteomics
Table 29: Population Breakup by Age Group for Select European Countries: 2012 (As a % of Total Population) (includes corresponding Graph/Chart)
European Personalized Medicine Market to Exhibit Robust Growth
Proteomics Market in Europe
Table 30: European Proteomics Market (2013): Percentage Breakdown of Deployment of Proteomics Technologies in End-Use Segment
Research and Academic Institutions, Pharmaceutical Companies, and Clinical Laboratories (includes corresponding Graph/Chart)
Proteomics Research in Europe
An Overview
Protein Identification Market
Protein Separation Market
Market Challenges
Gaining Edge in the Proteomics Industry
Player Strategies
European 2DE Market
Benefiting from Recession
New Product Developments
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 31: European Recent Past, Current & Future Analysis for Proteomics by Geographic Region
France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 32: European Historic Review for Proteomics by Geographic Region
France, Germany, Italy, UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
Table 33: European 15-Year Perspective for Proteomics by Geographic Region
Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)
4a. FRANCE
A.Market Analysis
French Proteomics Player
Hybrigenics Sa
B.Market Analytics
Table 34: French Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 35: French Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
4b. GERMANY
Market Analysis
Table 36: German Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 37: German Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
4c. ITALY
Market Analysis
Table 38: Italian Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 39: Italian Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Highlights
Increased Support for Personalized Medicine to Drive Proteomics Demand
Strategic Corporate Development
Key Player
Ge Healthcare
B.Market Analytics
Table 40: The UK Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 41: The UK Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
4e. REST OF EUROPE
A.Market Analysis
Key Swiss Player
Geneva Bioinformatics S.A.
B.Market Analytics
Table 42: Rest of European Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 43: Rest of European Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A.Market Analysis
Healthcare Spending in Asia-Pacific: On the Rise
China
Table 44: China
The Most Populous Country Worldwide (July 2013): Total Population (in Millions) by Age Group 0-14 Years, 15-44 Years, 45-64 Years, and 65+ Years for China Vis-a-Vis Other Countries (includes corresponding Graph/Chart)
Table 45: China
The Most Populous Country Worldwide (July 2013): Percentage Population by Age Group 0-14 Years, 15-44 Years, 45-64 Years, and 65+ Years for China Vis-a-Vis Other Countries (includes corresponding Graph/Chart)
Government Support Drives Personalized Medicine Market in China
Australia
India
Indian Scientific Research towards Functional Genomics and Proteomics
B.Market Analytics
Table 46: Asia-Pacific Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 47: Asia-Pacific Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)

6. LATIN AMERICA

Market Analysis
Table 48: Latin American Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 49: Latin American Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)

7. REST OF WORLD

Market Analysis
Table 50: Rest of World Recent Past, Current & Future Analysis for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 51: Rest of World Historic Review for Proteomics Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 82 (including Divisions/Subsidiaries 85)
The United States (54)
Canada (4)
Japan (2)
Europe (24)
France (3)
Germany (6)
The United Kingdom (7)
Spain (1)
Rest of Europe (7)
Asia-Pacific (Excluding Japan) (1)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos